２０２１（令和 3 年）
【著書】
1. 序文
伊藤 浩
編集 伊藤 浩高齢者の循環器診療 Q&A 文光堂, 東京, 2020/2/5
2. 高齢者で ABI と PWV(CAVI)を測定することの意義に関して教えてください
三好 亨
編集 伊藤 浩高齢者の循環器診療 Q&A pp33-34 文光堂, 東京, 2020/2/5
3. 高齢者における冠動脈石灰化スコアの意義に関して教えてください
三木崇史, 伊藤 浩
編集 伊藤 浩高齢者の循環器診療 Q&A pp35-36 文光堂, 東京, 2020/2/5
4. 高齢者静脈血栓塞栓症(VTE)の疫学と診断・治療に関して教えてください。DOAC はどこまでするのでしょうか？
吉田賢司
編集 伊藤 浩高齢者の循環器診療 Q&A pp41-42 文光堂, 東京, 2020/2/5
5. 高齢者の冠動脈疾患の診断はどのように行ったらよいでしょうか？
吉田雅言
編集 伊藤 浩高齢者の循環器診療 Q&A pp46-47 文光堂, 東京, 2020/2/5
6. 高齢者末梢動脈疾患(PAD)の治療適応と治療法に関して教えてください
戸田洋伸
編集 伊藤 浩高齢者の循環器診療 Q&A pp59-61 文光堂, 東京, 2020/2/5
7. 高齢高血圧患者に対しては ACE 阻害薬それとも ARB?
伊藤 浩
編集 伊藤 浩高齢者の循環器診療 Q&A pp81-82 文光堂, 東京, 2020/2/5
8. HFpEF 患者において心エコー図検査でどのような項目を評価したらよいのでしょうか？
中山理絵
編集 伊藤 浩高齢者の循環器診療 Q&A pp118-119 文光堂, 東京, 2020/2/5
9. 高齢者 HFpEF の心不全再入院を減らすためのポイントと薬物療法をどうすればよいか教
えてください伊藤 浩
編集 伊藤 浩高齢者の循環器診療 Q&A pp120-121 文光堂, 東京, 2020/2/5
10. 高齢者の心房細動の疫学とその合併症に関して教えてください伊藤 浩
編集 伊藤 浩高齢者の循環器診療 Q&A pp148-149 文光堂, 東京, 2020/2/5

11. 心房細動患者の左心耳閉鎖デバイスの適応と治療後の管理に関して教えてください中川晃志
編集 伊藤 浩高齢者の循環器診療 Q&A pp158-159 文光堂, 東京, 2020/2/5
12. 徐脈性不整脈とペースメーカ治療の適応について教えてください
森田 宏
編集 伊藤 浩高齢者の循環器診療 Q&A pp163-165 文光堂, 東京, 2020/2/5
13. 高齢者で増えている植込み型心臓電気デバイス感染症とリード抜去の適応に関して教えて
ください
西井伸洋
編集 伊藤 浩高齢者の循環器診療 Q&A pp166-167 文光堂, 東京, 2020/2/5
14. 序文伊藤 浩
編集 伊藤 浩
一からわかる循環器腎臓病学 文光堂, 東京, 2021/3/16
15. cardiorenal syndrome (CRS)とは？
中村一文
編集 伊藤 浩
一からわかる循環器腎臓病学 pp6-7 文光堂, 東京, 2021/3/16
16. CRS type 1 –急性心不全と AKI なぜ AKI が起きるか？
伊藤 浩
編集 伊藤 浩
一からわかる循環器腎臓病学 pp8-11 文光堂, 東京, 2021/3/16
17. CRS type 2 –慢性心不全と CKD 慢性期の利尿薬投与
伊藤 浩
編集 伊藤 浩
一からわかる循環器腎臓病学 pp33-35 文光堂, 東京, 2021/3/16
18. CRS type 2 –慢性心不全と CKD デバイス治療の有効性
西井伸洋
編集 伊藤 浩
一からわかる循環器腎臓病学 pp48-49 文光堂, 東京, 2021/3/16
19. Fontan 術後の CKD
杜 徳尚
編集 伊藤 浩
一からわかる循環器腎臓病学 pp63-65 文光堂, 東京, 2021/3/16
20. 疫学と機序 CKD で増加する冠動脈疾患
江尻健太郎
編集 伊藤 浩
一からわかる循環器腎臓病学 pp76-78 文光堂, 東京, 2021/3/16
21. 疫学と機序 尿毒素と動脈硬化
三好 亨
編集 伊藤 浩

一からわかる循環器腎臓病学 pp83-85 文光堂, 東京, 2021/3/16
22. 末梢動脈疾患 疫学と診断
戸田洋伸
編集 伊藤 浩
一からわかる循環器腎臓病学 pp114-117 文光堂, 東京, 2021/3/16
23. CKD と突然死
森田 宏
編集 伊藤 浩
一からわかる循環器腎臓病学 pp136-138 文光堂, 東京, 2021/3/16
24. 代償機転のレニン・アンジオテンシン・アルドステロン系の働きが心不全を悪化させる
中村一文, 戸田洋伸
編集 佐藤幸人
心不全診療アップグレード pp15-18 日本医事新報社, 東京, 2021/3/16
25. lf チャネル阻害薬
網岡尚史, 伊藤 浩
編集 筒井裕之
ザ・ベーシックメソッド 心不全 薬物治療 pp126-131 メジカルビュー社, 東京,
2021/3/31
26. 巻頭言赤木禎治, 伊藤 浩
編集 赤木禎治, 伊藤 浩
心疾患と妊娠・出産ベストプラクティス 南江堂, 東京, 2021/6/20
27. 妊娠・分娩の循環生理を理解する
赤木禎治
編集 赤木禎治, 伊藤 浩
心疾患と妊娠・出産ベストプラクティス pp2-6 南江堂, 東京, 2021/6/20
28. 心疾患患者の妊娠リスク評価
赤木禎治
編集 赤木禎治, 伊藤 浩
心疾患と妊娠・出産ベストプラクティス pp7-13 南江堂, 東京, 2021/6/20
29. 妊娠が心疾患に与える長期的影響を考える
中山理絵, 高谷陽一
編集 赤木禎治, 伊藤 浩
心疾患と妊娠・出産ベストプラクティス pp23-28 南江堂, 東京, 2021/6/20
30. 妊娠中の抗凝固療法
杜 徳尚
編集 赤木禎治, 伊藤 浩
心疾患と妊娠・出産ベストプラクティス pp86-93 南江堂, 東京, 2021/6/20
31. 妊娠中の手術・カテーテル治療
高谷陽一
編集 赤木禎治, 伊藤 浩
心疾患と妊娠・出産ベストプラクティス pp102-107 南江堂, 東京, 2021/6/20
32. 弁膜症
杜 徳尚

編集 赤木禎治, 伊藤 浩
心疾患と妊娠・出産ベストプラクティス pp176-182 南江堂, 東京, 2021/6/20【原著論文】
欧文：
33. Higher oxidized high-density lipoprotein to apolipoprotein A-I ratio is associated withhigh-risk coronary plaque characteristics determined by CT angiography.
Suruga K, Miyoshi T, Kotani K, Ichikawa K, Miki T, Osawa K, Ejiri K, Toda H,
Nakamura K, Morita H, Ito H.
Int J Cardiol. 2021 Feb 1;324:193-198. doi: 10.1016/j.ijcard.2020.09.060. Epub 2020
Sep 25.PMID: 32987049
34. Percutaneous closure of residual atrial septal defect after surgical closure.
Ogura S, Takaya Y, Akagi T, Nakagawa K, Ito H.
Cardiovasc Interv Ther. 2021 Apr;36(2):256-259. doi: 10.1007/s12928-020-00671-5.
Epub 2020 May 13.PMID: 32406034
35. Simple echocardiographic scoring in screening aortic stenosis with focused cardiac
ultrasonography in the emergency department.
Furukawa A, Abe Y, Morizane A, Miyaji T, Hosogi S, Ito H.
J Cardiol. 2021 Jun;77(6):613-619. doi: 10.1016/j.jjcc.2020.12.006. Epub 2020 Dec
29.PMID: 33386216
36. Efficacy of Saline Contrast Transthoracic Echocardiography for Identifying High-Risk
Patent Foramen Ovale.
Suruga K, Takaya Y, Nakayama R, Akagi T, Nakagawa K, Watanabe N, Haruna M,
Toh N, Ito H.
J Am Soc Echocardiogr. 2021 Jan;34(1):97-98. doi: 10.1016/j.echo.2020.08.001. Epub2020 Sep 2.PMID: 32888759
37. Pathological and clinical effects of interleukin-6 on human myocarditis.
Amioka N, Nakamura K, Kimura T, Ohta-Ogo K, Tanaka T, Toji T, Akagi S,
Nakagawa K, Toh N, Yoshida M, Miyoshi T, Nishii N, Watanabe A, Asano R, Ogo T,
Nakaoka Y, Morita H, Yanai H, Ito H.
J Cardiol. 2021 Aug;78(2):157-165. doi: 10.1016/j.jjcc.2021.03.003. Epub 2021 Apr
2.PMID: 3381425
38. Inhibitory effects of RAGE-aptamer on development of monocrotaline-induced
pulmonary arterial hypertension in rats.
Nakamura K, Akagi S, Ejiri K, Yoshida M, Miyoshi T, Sakaguchi M, Amioka N,
Suastika LOS, Kondo M, Nakayama R, Takaya Y, Higashimoto Y, Fukami K,
Matsubara H, Ito H.
J Cardiol. 2021 Jul;78(1):12-16. doi: 10.1016/j.jjcc.2020.12.009. Epub 2020 Dec
30.PMID: 33386219
39. Arterial stiffness in health and disease: The role of cardio-ankle vascular index.
Miyoshi T, Ito H.
J Cardiol. 2021 Aug 12:S0914-5087(21)00194-5. doi: 10.1016/j.jjcc.2021.07.011.
Online ahead of print.PMID: 34393004
40. Evolution of echocardiography in adult congenital heart disease: from pulsed-wave
Doppler to fusion imaging.
Toh N, Akagi T, Kasahara S, Ito H.
J Echocardiogr. 2021 May 28. doi: 10.1007/s12574-021-00533-w. Online ahead of

print.PMID: 34047950
41. Diagnosis, prevention, and treatment of cardiovascular diseases in people with type 2
diabetes and prediabetes: a consensus statement jointly from the Japanese Circulation
Society and the Japan Diabetes Society.
Araki E, Tanaka A, Inagaki N, Ito H, Ueki K, Murohara T, Imai K, Sata M, Sugiyama
T, Ishii H, Yamane S, Kadowaki T, Komuro I, Node K; directors of the JCS,JDS.
Diabetol Int. 2020 Nov 30;12(1):1-51. doi: 10.1007/s13340-020-00471-5. eCollection
2021 Jan.PMID: 33479578
42. Endocardial Hemangioma of the Right Ventricle: Complete Excision With Right
Ventricular Restoration.
Hirota M, Suezawa T, Kobayashi Y, Kawabata T, Kuroko Y, Kotani Y, Ito H,
Kasahara S.
Ann Thorac Surg. 2021 Jun;111(6):e411-e413. doi: 10.1016/j.athoracsur.2020.09.078.
Epub 2020 Dec 24.PMID: 33359506
43. Secular Decreasing Trend in Plasma Eicosapentaenoic and Docosahexaenoic Acids
among Patients with Acute Coronary Syndrome from 2011 to 2019: A Single Center
Descriptive Study.
Okada T, Miyoshi T, Doi M, Seiyama K, Takagi W, Sogo M, Nosaka K, Takahashi M,
Okawa K, Ito H.
Nutrients. 2021 Jan 17;13(1):253. doi: 10.3390/nu13010253.PMID: 33477264
44. Efficacy and safety of atrial septal defect closure using Occlutech Figulla Flex IIcompared with Amplatzer Septal Occluder.
Nakayama R, Takaya Y, Akagi T, Watanabe N, Miki T, Nakagawa K, Toh N, Ito
H.
Heart Vessels. 2021 May;36(5):704-709. doi: 10.1007/s00380-020-01739-1. Epub 2021
Jan 2.PMID: 33386412
45. Efficacy of treat-and-repair strategy for atrial septal defect with pulmonary arterial
hypertension.
Takaya Y, Akagi T, Sakamoto I, Kanazawa H, Nakazawa G, Murakami T, Yao A,
Nanasato M, Saji M, Hirokami M, Fuku Y, Hosokawa S, Tada N, Matsumoto K, Imai
M, Nakagawa K, Ito H.
Heart. 2021 Jun 15:heartjnl-2021-319096. doi: 10.1136/heartjnl-2021-319096. Online
ahead of print.PMID: 34415851
46. Morphological assessments of deficient posterior-inferior rim for transcatheter closureof atrial septal defect.
Takaya Y, Akagi T, Nakagawa K, Nakayama R, Miki T, Toh N, Ito H.
Catheter Cardiovasc Interv. 2021 Jan 1;97(1):135-141. doi: 10.1002/ccd.29182. Epub2020 Aug 13.PMID: 32790128
47. Prognostic value of non-alcoholic fatty liver disease for predicting cardiovascular eventsin patients with diabetes mellitus with suspected coronary artery disease: a prospective
cohort study.
Ichikawa K, Miyoshi T, Osawa K, Miki T, Toda H, Ejiri K, Yoshida M, Nanba Y,
Yoshida M, Nakamura K, Morita H, Ito H.
Cardiovasc Diabetol. 2021 Jan 7;20(1):8. doi:
10.1186/s12933-020-01192-4.PMID: 3341336
48. Fibrosis-4 index reflects right ventricular function and prognosis in heart failure withpreserved ejection fraction.

Nakashima M, Sakuragi S, Miyoshi T, Takayama S, Kawaguchi T, Kodera N, Akai H,
Koide Y, Otsuka H, Wada T, Kawamoto K, Tanakaya M, Katayama Y, Ito H.
ESC Heart Fail. 2021 Jun;8(3):2240-2247. doi: 10.1002/ehf2.13317. Epub 2021 Mar
24.PMID: 33760403
49. Efficacy of shear wave elastography for assessment of liver function in patients withheart failure.
Nakayama R, Takaya Y, Nakamura K, Toh N, Ito H.ESC Heart Fail. 2021
Jun;8(3):1751-1758. doi: 10.1002/ehf2.13318. Epub 2021 Mar 24.PMID: 33760377
50. Total vascular resistance, augmentation index, and augmentation pressure increase inpatients with peripheral artery disease.
Takemoto R, Uchida HA, Toda H, Okada K, Otsuka F, Ito H, Wada J.
Medicine (Baltimore). 2021 Aug 13;100(32):e26931. doi:
10.1097/MD.0000000000026931.PMID: 34397939
51. Efficacy and Safety of Sacubitril/Valsartan in Japanese Patients With Chronic Heart
Failure and Reduced Ejection Fraction - Results From the PARALLEL-HF Study.
Tsutsui H, Momomura SI, Saito Y, Ito H, Yamamoto K, Sakata Y, Desai AS, Ohishi T,
Iimori T, Kitamura T, Guo W; PARALLEL-HF Investigators.
Circ J. 2021 Apr 23;85(5):584-594. doi: 10.1253/circj.CJ-20-0854. Epub 2021 Mar
16.PMID: 33731544
52. Papillary-ventricular complex tugging for ischemic/functional mitral regurgitation.
Hirota M, Suezawa T, Kawabata T, Kuroko Y, Kotani Y, Yokohama F, Takaya Y, Ito
H, Kasahara S.
Ann Thorac Surg. 2021 Apr 20:S0003-4975(21)00710-4. doi:
10.1016/j.athoracsur.2021.03.095. Online ahead of print.PMID: 33891917
53. Incremental prognostic value of non-alcoholic fatty liver disease over coronary
computed tomography angiography findings in patients with suspected coronary arterydisease.
Ichikawa K, Miyoshi T, Osawa K, Miki T, Toda H, Ejiri K, Yoshida M, Nakamura K,
Morita H, Ito H.
Eur J Prev Cardiol. 2021 Jul 19:zwab120. doi: 10.1093/eurjpc/zwab120. Online aheadof print.PMID: 34279027
54. Prognosis of patients with severe left ventricular dysfunction after transvenous leadextraction and the need for additional hemodynamic support in the perioperative
period.
Nishii N, Nishimoto T, Mizuno T, Masuda T, Asada S, Miyamoto M, Kawada S,
Nakagawa K, Nakamura K, Morita H, Morimatsu H, Kasahara S, Ito H.
Heart Rhythm. 2021 Jun;18(6):962-969. doi: 10.1016/j.hrthm.2021.01.026. Epub 2021
Jan 29.PMID: 33516947
55. Comparison between cryoballoon and hot balloon ablation in patients with paroxysmal
atrial fibrillation.
Suruga K, Suenari K, Nakano T, Takemoto H, Hashimoto Y, Tomomoi S, Higaki T,
Dai K, Oi K, Kawase T, Nakama Y, Nishioka K, Otsuka M, Masaoka Y, Shiode N, Ito
H.
J Interv Card Electrophysiol. 2021 Mar 16. doi: 10.1007/s10840-021-00978-0. Online
ahead of print.PMID: 33728551
56. Preventative effects of bisoprolol transdermal patches on postoperative atrial
fibrillation in high-risk patients undergoing non-cardiac surgery: A subanalysis of the
MAMACARI study.

Iwano T, Toda H, Nakamura K, Shimizu K, Ejiri K, Naito Y, Mori H, Masuda T,
Miyoshi T, Yoshida M, Hikasa Y, Morimatsu H, Ito H; MAMACARI Investigators.
J Cardiol. 2021 Jun 1:S0914-5087(21)00113-1. doi: 10.1016/j.jjcc.2021.05.001. Online
ahead of print.PMID: 34083113
57. Feasibility of transcatheter closure for absent aortic rim in patients with atrial septal
defect.
Takaya Y, Akagi T, Nakagawa K, Nakayama R, Miki T, Toh N, Ito H.
Catheter Cardiovasc Interv. 2021 Apr 1;97(5):859-864. doi: 10.1002/ccd.29457. Epub
2021 Jan 18.PMID: 33458916
58. Efficacy of shear wave elastography for evaluating right ventricular myocardial fibrosis
in monocrotaline-induced pulmonary hypertension rats.
Nakayama R, Takaya Y, Nakamura K, Kondo M, Kobayashi K, Ohno Y, Amioka N,
Akagi S, Yoshida M, Miyoshi T, Ito H.
J Cardiol. 2021 Jul;78(1):17-23. doi: 10.1016/j.jjcc.2021.01.015. Epub 2021 Feb
7.PMID: 33568315
59. Usefulness of cardiac fusion imaging with computed tomography and Doppler
echocardiography in the assessment of conduit stenosis in complex adult congenital
heart disease.
Watanabe N, Toh N, Takaya Y, Nakayama R, Yokohama F, Osawa K, Miyoshi T,
Akagi T, Kanazawa S, Ito H.
J Cardiol. 2021 Jul 12:S0914-5087(21)00166-0. doi: 10.1016/j.jjcc.2021.06.008. Online
ahead of print.PMID: 34266716
60. Low-Angle Patent Foramen Ovale (PFO): High-Risk PFO Morphology Associated with
Paradoxical Embolism.
Nakayama R, Takaya Y, Akagi T, Miki T, Nakagawa K, Toh N, Ito H.
CASE (Phila). 2021 Apr 2;5(3):183-185. doi: 10.1016/j.case.2021.02.008. eCollection
2021 Jun.PMID: 34195519
61. High Plasma Docosahexaenoic Acid Associated to Better Prognoses of Patients with
Acute Decompensated Heart Failure with Preserved Ejection Fraction.
Matsuo N, Miyoshi T, Takaishi A, Kishinoue T, Yasuhara K, Tanimoto M, Nakano Y,
Onishi N, Ueeda M, Ito H.
Nutrients. 2021 Jan 26;13(2):371. doi: 10.3390/nu13020371.PMID: 33530352
62. Fusion imaging of three-dimensional echocardiographic speckle-tracking with cardiac
computed tomography for identification of myocardial ischemia.
Takaya Y, Nakayama R, Watanabe N, Toh N, Miyoshi T, Ito H.
Health Sci Rep. 2021 Jun 18;4(2):e285. doi: 10.1002/hsr2.285. eCollection 2021
Jun.PMID: 34189272
63. Multiple Late Complications After Takeuchi Repair of Anomalous Left Coronary Artery
From the Pulmonary Artery.
Yokohama F, Toh N, Kotani Y, Watanabe N, Takaya Y, Akagi T, Kasahara S, Ito
H.
JACC Case Rep. 2021 May 19;3(5):731-735. doi: 10.1016/j.jaccas.2021.02.035.
eCollection 2021 May.PMID: 3431761
64. Effects of Dual Initial Combination Therapy With Macitentan Plus Riociguat orMacitentan Plus Selexipag on Hemodynamics in Patients With Pulmonary Arterial
Hypertension (SETOUCHI-PH Study) - Protocol of a Multicenter Randomized Control
Trial.
Akagi S, Dohi Y, Ishikawa K, Kubota K, Horimoto K, Yagi S, Hirata T, Yamamoto

E, Ito H, Nakamura K.
Circ Rep. 2021 Jan 9;3(2):105-109. doi: 10.1253/circrep.CR-20-0133.PMID: 3369329
65. Predictive Value of the Cardio-Ankle Vascular Index for Cardiovascular Events inPatients at Cardiovascular Risk.
Miyoshi T, Ito H, Shirai K, Horinaka S, Higaki J, Yamamura S, Saiki A, Takahashi M,
Masaki M, Okura T, Kotani K, Kubozono T, Yoshioka R, Kihara H, Hasegawa K,
Satoh-Asahara N, Orimo H; CAVI‐J (Prospective Multicenter Study to Evaluate
Usefulness of Cardio‐Ankle Vascular Index in Japan) investigators *.
J Am Heart Assoc. 2021 Aug 17;10(16):e020103. doi: 10.1161/JAHA.120.020103. Epub
2021 Aug 7.PMID: 34369198
66. Effect of preprocedural pharmacologic cardioversion on pulmonary vein isolation inpatients with persistent atrial fibrillation.
Okawa K, Hara S, Morimoto T, Tsushima R, Sudo Y, Sogo M, Ozaki M, Takahashi M,
Doi M, Morita H, Ito H.
Heart Rhythm. 2021 Apr 28:S1547-5271(21)00406-9. doi:
10.1016/j.hrthm.2021.04.027. Online ahead of print.PMID: 33932587
67. Electron Microscopy Revealed Massive Lipid Droplets in Cardiomyocytes in a Patientwith Cardiogenic Shock Following a Fulminant Type 1 Diabetes Mellitus.
Sugawara R, Sugiyama H, Nakamura K, Tohgi K, Hongo T, Tsuchiya M, Momoki N,
Nose S, Yutani C, Ikeda Y, Ikeda T, Ito H.
Int Heart J. 2021;62(1):197-200. doi: 10.1536/ihj.20-537.PMID: 33518659
68. Increased Circulating Malondialdehyde-Modified Low-Density Lipoprotein Level Is
Associated with High-Risk Plaque in Coronary Computed Tomography Angiography inPatients Receiving Statin Therapy.
Ichikawa K, Miyoshi T, Osawa K, Miki T, Ito H.
J Clin Med. 2021 Apr 2;10(7):1480. doi: 10.3390/jcm10071480.PMID: 33918383
69. Efficacy and Safety of Early Intravenous Landiolol on Myocardial Salvage in Patientswith ST-segment Elevation Myocardial Infarction before Primary PercutaneousCoronary Intervention: A Randomized Study.
Miyamoto M, Osawa K, Miyoshi T, Mori A, Yoshikawa M, Oka T, Ichikawa K,
Nakamura K, Ito H.
Acta Med Okayama. 2021 Jun;75(3):289-297. doi:
10.18926/AMO/62220.PMID: 34176932
70. Possible Protective Effect of Remote Ischemic Preconditioning on Acute Kidney Injury
Following Elective Percutaneous Coronary Intervention: Secondary Analysis of aMulticenter, Randomized Study.
Otsuka H, Miyoshi T, Ejiri K, Kohno K, Nakahama M, Doi M, Munemasa M,
Murakami M, Nakamura K, Ito H.
Acta Med Okayama. 2021 Feb;75(1):45-53. doi:
10.18926/AMO/61433.PMID: 33649613
71. Usefulness of right ventriculography compared with computed tomography for rulingout the possibility of lead perforation before lead extraction.
Asada S, Nishii N, Shinya T, Miyoshi A, Morimoto Y, Miyamoto M, Nakagawa K,
Nakamura K, Morita H, Ito H.
PLoS One. 2021 Mar 4;16(3):e0245502. doi: 10.1371/journal.pone.0245502. eCollection
2021.PMID: 33661956
72. Who is at high-risk in J wave syndromes?

Morita H, Miyamoto M.
Trends Cardiovasc Med. 2021 Aug 10:S1050-1738(21)00087-6. doi:
10.1016/j.tcm.2021.08.003. Online ahead of print.PMID: 34389408
73. Functionally validated SCN5A variants allow interpretation of pathogenicity andprediction of lethal events in Brugada syndrome.
Ishikawa T, Kimoto H, Mishima H, Yamagata K, Ogata S, Aizawa Y, Hayashi
K, Morita H, Nakajima T, Nakano Y, Nagase S, Murakoshi N, Kowase S, Ohkubo K,
Aiba T, Morimoto S, Ohno S, Kamakura S, Nogami A, Takagi M, Karakachoff M, Dina
C, Schott JJ, Yoshiura KI, Horie M, Shimizu W, Nishimura K, Kusano K, Makita
N.
Eur Heart J. 2021 Jul 31;42(29):2854-2863. doi:
10.1093/eurheartj/ehab254.PMID: 34219138
74. Diagnosis of wild-type transthyretin amyloid cardiomyopathy in Japan: red-flag
symptom clusters and diagnostic algorithm.
Inomata T, Tahara N, Nakamura K, Endo J, Ueda M, Ishii T, Kitano Y, Koyama
J.
ESC Heart Fail. 2021 Aug;8(4):2647-2659. doi: 10.1002/ehf2.13473. Epub 2021 Jun
17.PMID: 34137515
75. Heart Failure Association, Heart Failure Society of America, and Japanese Heart
Failure Society Position Statement on Endomyocardial Biopsy.
Seferović PM, Tsutsui H, Mcnamara DM, Ristić AD, Basso C, Bozkurt B, Cooper LT,
Filippatos G, Ide T, Inomata T, Klingel K, Linhart A, Lyon AR, Mehra MR, Polovina
M, Milinković I, Nakamura K, Anker SD, Veljić I, Ohtani T, Okumura T, Thum T,
Tschöpe C, Rosano G, Coats AJS, Starling RC.
J Card Fail. 2021 Jul;27(7):727-743. doi: 10.1016/j.cardfail.2021.04.010. Epub 2021
May 19.PMID: 34022400
76. Heart Failure Association of the ESC, Heart Failure Society of America and JapaneseHeart Failure Society Position statement on endomyocardial biopsy.
Seferović PM, Tsutsui H, McNamara DM, Ristić AD, Basso C, Bozkurt B, Cooper LT
Jr, Filippatos G, Ide T, Inomata T, Klingel K, Linhart A, Lyon AR, Mehra MR,
Polovina M, Milinković I, Nakamura K, Anker SD, Veljić I, Ohtani T, Okumura T,
Thum T, Tschöpe C, Rosano G, Coats AJS, Starling RC.
Eur J Heart Fail. 2021 Jun;23(6):854-871. doi: 10.1002/ejhf.2190. Epub 2021 May
19.PMID: 3401047
77. Cardio-Ankle Vascular Index and Atrial Remodeling for Atrial Fibrillation.
Miyoshi T.
J Atheroscler Thromb. 2021 Jun 1;28(6):584-585. doi: 10.5551/jat.ED148. Epub 2020
Nov 18.PMID: 33208567
78. Lack of collagen α6(IV) chain in mice does not cause severe-to-profound hearing loss orcochlear malformation, a distinct phenotype from nonsyndromic hearing loss with
COL4A6 missense mutation.
Tang S, Yonezawa T, Maeda Y, Ono M, Maeba T, Miyoshi T, Momota R, Tomono Y,
Oohashi T.
PLoS One. 2021 Apr 13;16(4):e0249909. doi: 10.1371/journal.pone.0249909.
eCollection 2021.PMID: 33848312
79. Safety and Long-term Outcomes of Defibrillator Therapy in Patients With Right-Sided
Implantable Cardiac Devices in Adults With Congenital Heart Disease.
Kawada S, Chakraborty P, Albertini L, Bhaskaran A, Oechslin EN, Sliversides C,

Wald RM, Roche SL, Harris L, Swan L, Alonso-Gonzalez R, Thorne S, Downar E,
Nanthakumar K, Mondésert B, Khairy P, Nair K.
Can J Cardiol. 2021 Mar;37(3):407-416. doi: 10.1016/j.cjca.2020.05.038. Epub 2020
Jun 6.PMID: 32522524
80. The Role of Ablation in Prevention of Recurrent Implantable Cardioverter Defibrillator
Shocks in Patients With Tetralogy of Fallot.
Kawada S, Chakraborty P, Downar E, Sanchez AP, Sathananthan G, Bhaskaran A,
Kugamoorthy P, Albertini L, Oechslin EN, Silversides C, Wald RM, Roche SL, Swan L,
Alonso-Gonzalez R, Thorne S, Harris L, Hickey E, Nanthakumar K, Mondésert B,
Khairy P, Nair K.
CJC Open. 2021 Jan 28;3(5):619-626. doi: 10.1016/j.cjco.2021.01.005. eCollection 2021
May.PMID: 34027366
81. Transcatheter closure of patent foramen ovale: Current evidence and future
perspectives.
Akagi T.
J Cardiol. 2021 Jan;77(1):3-9. doi: 10.1016/j.jjcc.2020.09.005. Epub 2020 Nov
2.PMID: 33144025
82. Bleeding and thrombotic risk in pregnant women with Fontan physiology.
Girnius A, Zentner D, Valente AM, Pieper PG, Economy KE, Ladouceur M,
Roos-Hesselink JW, Warshak C, Partington SL, Gao Z, Ollberding N, Faust M,
Girnius S, Kaemmerer H, Nagdyman N, Cohen S, Canobbio M, Akagi T, Grewal J,
Bradley E, Buber Y, Palumbo J, Walker N, Aboulhosn J, Oechslin E, Baumgartner H,
Kurdi W, Book WM, Mulder BJM, Veldtman GR.
Heart. 2021 Sep;107(17):1390-1397. doi: 10.1136/heartjnl-2020-317397. Epub 2020
Nov 24.PMID: 33234672
83. European position paper on the management of patients with patent foramen ovale.
Part II - Decompression sickness, migraine, arterial deoxygenation syndromes andselect high-risk clinical conditions.
Pristipino C, Germonpré P, Toni D, Sievert H, Meier B, D'Ascenzo F, Berti S, Onorato
EM, Bedogni F, Mas JL, Scacciatella P, Hildick-Smith D, Gaita F, Kyrle PA, Thomson
J, Derumeaux G, Sibbing D, Chessa M, Hornung M, Zamorano J, Dudek D;
EVIDENCE SYNTHESIS TEAM, D'Ascenzo F, Omedè P, Ballocca F, Barbero U,
Giordana F, Gili S, Iannaccone M; INTERNATIONAL EXPERTS, Akagi T, Anzola G,
Carroll J, Dalvi B, Angelis C, Junbo G, Kasner SE, Michel-Behnke I, Musumeci G,
Søndergaard L, Tarantini G, Biondi-Zoccai GGL; joint task force of European
Association of Percutaneous Cardiovascular Interventions (EAPCI), European Stroke
Organisation (ESO), European Heart Rhythm Association (EHRA), European
Association for Cardiovascular Imaging (EACVI), European Paediatric andCongenital Cardiology (AEPC), ESC Working Group on Adult Congenital Heart
Disease, ESC Working Group on Thrombosis, European Haematological Society(EHA), European Underwater and Baromedical Society (EUBS); EAPCI SCIENTIFIC
DOCUMENTS AND INITIATIVES COMMITTEE, Capodanno D, Valgimigli M,
Byrne R, Kunadian V.
Eur Heart J. 2021 Apr 21;42(16):1545-1553. doi:
10.1093/eurheartj/ehaa1070.PMID: 33507260
84. Cost-Effectiveness Analysis of Percutaneous Patent Foramen Ovale Closure Preventing
Secondary Ischemic Stroke in Japan.
Inoue S, Igarashi A, Iguchi Y, Akagi T.

J Stroke Cerebrovasc Dis. 2021 Aug;30(8):105884. doi:
10.1016/j.jstrokecerebrovasdis.2021.105884. Epub 2021 Jun 18.PMID: 34153592
85. Rationale and design of the HINODE study: Heart failure indication and sudden
cardiac death prevention trial Japan.
Yamasaki H, Ando K, Ikeda T, Mitsuhashi T, Murohara T, Nishii N, Nogami A,
Sakata Y, Shimizu W, Simon T, Beaudoint C, Kayser T, Kutyifa V, Aonuma K.
J Arrhythm. 2021 Jul 20;37(4):1031-1037. doi: 10.1002/joa3.12577. eCollection 2021
Aug.PMID: 34386129
86. Risk factors for the first and second inappropriate implantablecardioverter-defibrillator therapy.
Nishii N, Noda T, Nitta T, Aizawa Y, Ohe T, Kurita T.
Int J Cardiol Heart Vasc. 2021 Apr 26;34:100779. doi: 10.1016/j.ijcha.2021.100779.
eCollection 2021 Jun.PMID: 33997254【総説】
和文：
87. 巻頭言 三尖弁について語ろう
杜 徳尚, 伊藤 浩
心エコー 22(5): 383-383, 2021/5/1
88. 成人期に診る Ebstein 病
杜 徳尚
心エコー 22(5): 460-466, 2021/5/1
89. 巻頭言 経食道心エコーの新ルール!
丸尾 健, 伊藤 浩
心エコー 22(6): 485-485, 2021/6/1
90. 心房中隔欠損精査のルール
中山理絵, 高谷陽一
心エコー 22(6): 568-574, 2021/6/1
91. 左室収縮能－どの指標が正しい？
横濱ふみ, 杜 徳尚
心エコー 22(8); 732-739, 2021/8/1
92. サクビトリルバルサルタンの特性 2) サクビトリルバルサルタンの作用機序と特徴
江尻健太郎, 伊藤 浩
PROGRESS IN MEDICINE 41(4): 355-359, 2021.
93. 遺伝性不整脈の薬物治療 up-to-date
森田 宏Heart View 25(7): 674-680, 2021/7/9
94. 汎用心電計による心房細動関連不適切診断の現状と問題点
加藤貴雄, 八島正明, 高橋尚彦, 渡邉英一, 池田隆徳, 笠巻祐二, 住友直方, 植田典浩,
森田 宏, 平岡昌和
心電図 41(1): 5-13, 2021.
95. 海外文献紹介 Selected Papers 基礎 「アクチビン受容体 IIA 型-Fc 融合蛋白質を用いた,
アクチビン/GDF と BMP シグナルのリバランスによる肺高血圧症治療」
中村一文, 赤木 達, 松原広己

Pulmonary Hypertension Update 7(1): 54-55, 2021/5
96. 特集 卵円孔開存の問題と新しい治療 はじめに
赤木禎治
医学のあゆみ 276(4): 253-253, 2021.
97. 脳梗塞以外の病態と卵円孔開存 - 片頭痛, 減圧病, platypnea-orthodeoxia syndrome
高谷陽一
医学のあゆみ 276(4): 291-294, 2021.
98. ファロー四徴症
赤木禎治
日本医事新報 (5053): 41-42, 2021.
99. ACE 阻害薬
卜部 力, 伊藤 浩
日本医事新報 31-50, 2021
100.
Amplatzer PFO 閉鎖栓を用いた卵円孔開存のカテーテル閉鎖術
赤木禎治
Cardio-Coagulation 8(2): 108-112, 2021.
101.
遠隔モニタリング
西井伸洋
医学と薬学 78(5): 549-556, 2021.
102.
成人先天性心疾患に対する心臓超音波検査の実際
杜 徳尚
103.

インナービジョン 36(5): 44-47, 2021.
SGLT2 阻害薬 (ダパグリフロジン, エンパグリフロジン)

江尻健太郎
Therapeutic Research 42(3): 180-187, 2021.
104.
超音波診断装置の技術革新が広げる循環器画像診断の可能性 3)成人先天性心疾患に対する心臓超音波検査の実際
杜 徳尚
INNERVISION 36(5): 44-47, 2021/4/25
105.
HFmrEF(heart failure with mid-range ejection fraction)
卜部 力, 伊藤 浩
日本臨床 79(8): 1184-1189, 2021/8/1
106.
ミネラルコルチコイド受容体拮抗薬のトピックス
市川啓之, 伊藤 浩
循環器内科 90(1): 99-104, 2021/7/28
107.
薬剤封入ナノ粒子を用いた Drug Delivery System による肺動脈性肺高血圧の治療法
開発
中村一文, 赤木 達, 伊藤 浩
Medical Science Digest 47(1): 43-45, 2021/1/25
108.
治療【植込み型デバイス】CRT/CRTD
西井伸洋
CATH LAB JIN 4(2): 95-98, 2021/4/30

109.

糖尿病治療が変わる
伊藤 浩
BIO Clinica 35(8): 4-5, 2021

欧文：
110.
After seven years as Editor-in-Chief, it's time to pass the baton.
Ito H.
J Cardiol. 2021 Jan;77(1):1. doi: 10.1016/j.jjcc.2020.10.017. Epub 2020 Nov
16.PMID: 33214050
【その他】
111.
書評 国循・天理よろづ印 心エコー読影ドリル【Web 動画付】 泉 知里(編)伊藤 浩
検査と技術 49(8); 924, 2021/8/1